Abstract
To compare the functions of the lateral olfactory tubercle (OT) and the medial nucleus accumbens (ACC), dopamine (DA), (3,4-dihydroxyphenylimino)-2-imidazoline (DPI), and ergometrine were injected into the brain of rats familiarized with the experimental cage in which locomotor activity was assessed. In all tests a volume of 0.5 μl per side was used. Both DA (1–10 μg) and apomorphine (1–10 μg) increased locomotor activity when injected into the OT; similar injections into the ACC produced inconsistent effects. The OT effects were short-lasting, dose-dependent and antagonized by haloperidol (0.5–2.5 μg) in a dose-dependent manner. DPI (1–10 μg) too produced an increase when injected into the OT; this response was long-lasting, dose-dependent and potentiated by ergometrine (0.1–1.0 μg). Ergometrine (0.1–1.0 μg) dose-dependently increased activity over a period of 200 min in ACC and OT rats, although the response in OT rats was much smaller than that in ACC rats. Only the ergometrine response in ACC rats was dose-dependently suppressed by DPI (1–10 μg). ACC rats tested during the light period showed a weak stimulatory response to ergometrine in comparison with ACC rats tested during the dark period; OT rats showed reversed light/dark periodicity. Thus, OT rats significantly differed from ACC rats with respect to locomotor responses to dopaminergic agents, their pharmacological profile and their light/dark periodicity. Evidence is provided that the lateral tuberculum, but not the medial accumbens, is responsible for the stimulatory effect of dopamine and related compounds.
Similar content being viewed by others
References
Andén NE, Jackson DM (1975) Locomotor activity stimulation in rats produced by dopamine in the nucleus accumbens: potentiation by caffeine. J Pharm Pharmacol 27:666–670
Arnt J, Bogeso K, Christensen A, Hyttel J, Larsen J, Svendsen O (1983) Dopamine receptor agonistic and antagonist effects of 3-PPP enantiomers. Psychopharmacology 81:199–207
Beninger RJ (1983) The role of dopamine in locomotor activity and learning. Brain Res Rev 6:173–196
Cools AR (1977) Two functionally and pharmacologically distinct dopamine receptors in the rat brain. In: Costa E, Gessa GL (eds) Advances in biochemical pharmacology, vol 16. Raven Press, New York, pp 215–225
Cools AR, Oosterloo SK (1983) (3,4-Dihydroxyphenylimino)-2-imidazoline (DPI) and its action at noradrenergic and dopaminergic receptors in the nucleus accumbens of rats: mesolimbic catecholamine receptors and hyperactivity. J Neural Transm suppl 18:181–188
Cools AR, Van Rossum JM (1980) Multiple receptors for brain dopamine in behavioural regulation: concept of dopamine-e and dopamine-i receptors. Life Sci 27:1237–1253
Cools AR, Honig WMM, Pijnenburg AJJ, Van Rossum JM (1976) The nucleus accumbens of rats and dopaminergic mechanisms regulating locomotor behaviour. Neurosci Lett 3:335–339
Costall B, Naylor RJ (1976) A comparison of the abilities of typical neuroleptic agents and thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic system. Eur J Pharmacol 40:9–19
Costall B, Hui S-CG, Naylor RJ (1979) Differential effects of (3,4-di-hydroxyphenylamino)-2-imidazoline (DPI) on hyperactivity responses to dopamine agonists injected into the nucleus accumbens. J Pharm Pharmacol 31:478–480
Costall B, Fortune DH, Hui S-C, Naylor RJ (1980) Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interaction at presynaptic receptors? Eur J Pharmacol 63:347–358
Elkawad AO, Woodruff GN (1975) Studies on the behavioural pharmacology of a cyclic analogue of dopamine following its injection into the brain of conscious rats. Br J Pharmacol 54:107–114
Fallon JH, Moore RY (1978) Catecholamine inervation of the basal forebrain IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J Comp Neurol 180:545–580
Ferguson GA (1981) Statistical analysis in psychology and education. McGraw-Hill International Book Company, Singapore, pp 251–293
Grabowska M, Andén NE (1976) Apomorphine in the rat nucleus accumbens: effects on the synthesis of 5-hydroxytrypamine and noradrenaline, the motor activity and the body temperature. J Neural Transm 38:1–8
Hjorth S, Carlsson A, Wikström H, Lindberg P, Sanchez D, Hacksell U, Arvidsson L-E, Svensson U, Nilsson JLG (1981) 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors, Life Sci 28:1225–1238
Jackson DM, Anden Ne, Dahlström A (1975) A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain. Psychopharmacologia 45:139–149
Kalkman HO, Van Gelderen EM, Timmermans PBMWM, Van Zwieten PA (1982) Involvement of α1- and α2-adrenoceptors in the vasoconstriction caused by ergometrine. Eur J Pharmacol 78:107–111
Kelly PH, Serviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507–522
König FRJ, Klippel RA (1963) The rat brain. The Williamson and Wilkins Comp., Baltimore
Lorens SA, Sorensen JP, Harvey JA (1970) Lesions in the nuclei accumbens septi of the rat: behavioral and neurochemical effects. J Comp Physiol Psychol 73:284–290
Makanjuola ROA, Dow RC, Ashcroft GW (1980) Behavioural responses to stereotaxically controlled injections of monoamine neurotransmitters into the accumbens and caudate-putamen nuclei. Psychopharmacology 71:227–235
Oene JC van, Houwing HA, Horn AS (1982) Evidence that the purported dopaminergic agonist (3,4-dihydroxyphenylimino)-2-imidazoline (DPI) may reduce rat striatal dopamine turnover by an α2-adrenergic mechanism. Eur J Pharmacol 81:75–87
Pijnenburg AJJ, Van Rossum JM (1973) Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens. J Pharm Pharmacol 25:1003–1005
Pijnenburg AJJ, Woodruff GN, Van Rossum JM (1973) Ergometrine-induced locomotor activity following intracerebral injection into the nucleus accumbens. Brain Res 59:289–302
Pijnenburg AJJ, Honig WMM, Van der Heyden JAM, Van Rossum (1976a) Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Eur J Pharmacol 35:45–58
Pijnenburg AJJ, Honig WMM, Struyker Boudier HAJ, Cools AR, Van der Heyden JAM, Van Rossum JM (1976b) Further investigations on the effects of ergometrine and other ergot derivatives following injection into the nucleus accumbens of rats. Arch Int Pharmacodyn 222:103–115
Ree JM van, Wolterink G (1981) Injection of low doses of apomorphine into rats reduces locomotor activity. Eur J Pharmacol 72:107–111
Seeman P (1981) Brain dopamine receptors. Pharmacol Rev 32:229–313
Slater P, Longman DA, Dickinson SL (1982) Effects of intrapallidal drugs on hyperactivity induced by nucleus accumbens dopamine receptor stimulation. Naunyn-Schmiedeberg's Arch Pharmakol 321:201–206
Struyker Boudier HAJ, Cools AR (1984) DPI: stimulant of α-adrenoceptors and dopamine receptors. J Pharm Pharmacol 36:859–860
Struyker Boudier HAJ, De Boer J, Smeets G, Lien E, Van Rossum JM (1975) Structure-activity relationships for cerebral and peripheral α-adrenergic activity of imidazoline derivatives. Life Sci 17:377–386
Svensson L, Ahlenius S (1983) Suppression of exploratory locomotor activity in the rat by the local application of 3-PPP enantiomers into the nucleus accumbens. Eur J Pharmacol 88:393–397
Swanson LW (1982) The projection of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull 9:321–353
Author information
Authors and Affiliations
Additional information
The results were presented during the 14th C.I.N.P. Congress (Collegium International Neuro-Psychopharmacologicum), held at Florence (Italy), June 19–23, 1984
Rights and permissions
About this article
Cite this article
Cools, A.R. Mesolimbic dopamine and its control of locomotor activity in rats: differences in pharmacology and light/dark periodicity between the olfactory tubercle and the nucleus accumbens. Psychopharmacology 88, 451–459 (1986). https://doi.org/10.1007/BF00178506
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00178506